Peptide prices vary with synthesis difficulty, purity level, testing, quantity, and sourcing. A longer or harder-to-make sequence, a higher purity target, and thorough third-party testing all raise the cost.
What drives the price
- Sequence difficulty: longer or more complex peptides take more synthesis steps.
- Purity target: reaching and verifying 99%+ requires more purification.
- Testing: independent, batch-by-batch testing adds real cost.
- Quantity and scale: amount per vial and order size affect unit price.
- Sourcing: the manufacturer and quality standards behind the material.
When cheap is a warning
A rock-bottom price can be a red flag. It may reflect lower purity, minimal testing, or missing documentation. The certificate of analysis is how you tell whether a lower price reflects genuine value or a corner that was cut.
Key takeaways
- Prices vary with synthesis difficulty, purity, testing, quantity, and sourcing.
- Longer sequences and higher purity cost more to produce and verify.
- Thorough third-party testing adds real, worthwhile cost.
- A suspiciously low price can signal lower purity or missing testing.
A note on research use
The peptides supplied by Axis Peptide Labs are reference compounds for laboratory and research use only. They are intended for qualified researchers working in academic, institutional, and analytical settings. They are not drugs, foods, cosmetics, or medical products, and they are not intended for human or veterinary consumption. Documented identity and documented purity are what matter most when sourcing a compound, both of which are published on the Axis certificates of analysis page.
